Literature DB >> 15654766

Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).

Fumie Nakazawa1, Christian Kannemeier, Aya Shibamiya, Yutong Song, Eleni Tzima, Uwe Schubert, Takatoshi Koyama, Michael Niepmann, Heidi Trusheim, Bernd Engelmann, Klaus T Preissner.   

Abstract

FSAP (Factor VII-activating protease) is a new plasma-derived serine protease with putative dual functions in haemostasis, including activation of coagulation Factor VII and generation of urinary-type plasminogen activator (urokinase). The (auto-)activation of FSAP is facilitated by polyanionic glycosaminoglycans, such as heparin or dextran sulphate, whereas calcium ions stabilize the active form of FSAP. In the present study, extracellular RNA was identified and characterized as a novel FSAP cofactor. The conditioned medium derived from various cell types such as smooth muscle cells, endothelial cells, osteosarcoma cells or CHO (Chinese-hamster ovary) cells contained an acidic factor that initiated (auto-)activation of FSAP. RNase A, but not other hydrolytic enzymes (proteases, glycanases and DNase), abolished the FSAP cofactor activity, which was subsequently isolated by anion-exchange chromatography and unequivocally identified as RNA. In purified systems, as well as in plasma, different forms of natural RNA (rRNA, tRNA, viral RNA and artificial RNA) were able to (auto-)activate FSAP into the two-chain enzyme form. The specific binding of FSAP to RNA (but not to DNA) was shown by mobility-shift assays and UV crosslinking, thereby identifying FSAP as a new extracellular RNA-binding protein, the K(D) estimated to be 170-350 nM. Activation of FSAP occurred through an RNA-dependent template mechanism involving a nucleic acid size of at least 100 nt. In a purified system, natural RNA augmented the FSAP-dependent Factor VII activation several-fold (as shown by subsequent Factor Xa generation), as well as the FSAP-mediated generation of urokinase. Our results provide evidence for the first time that extracellular RNA, present at sites of cell damage or vascular injury, can serve an important as yet unrecognized cofactor function in haemostasis by inducing (auto-)activation of FSAP through a novel surface-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654766      PMCID: PMC1134760          DOI: 10.1042/BJ20041021

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  A protease isolated from human plasma activating factor VII independent of tissue factor.

Authors:  J Römisch; A Feussner; S Vermöhlen; H A Stöhr
Journal:  Blood Coagul Fibrinolysis       Date:  1999-12       Impact factor: 1.276

2.  Stability of endogenous and added RNA in blood specimens, serum, and plasma.

Authors:  Nancy B Y Tsui; Enders K O Ng; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

3.  Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.

Authors:  C Kannemeier; A Feussner; H A Stöhr; J Weisse; K T Preissner; J Römisch
Journal:  Eur J Biochem       Date:  2001-07

4.  Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism.

Authors:  M Etscheid; A Hunfeld; H König; R Seitz; J Dodt
Journal:  Biol Chem       Date:  2000-12       Impact factor: 3.915

Review 5.  Conserved structures and diversity of functions of RNA-binding proteins.

Authors:  C G Burd; G Dreyfuss
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

Review 6.  Factor VII activating protease (FSAP): a novel protease in hemostasis.

Authors:  Jügrgen Römisch
Journal:  Biol Chem       Date:  2002 Jul-Aug       Impact factor: 3.915

7.  Hepatic injury-specific conversion of mouse plasma hyaluronan binding protein to the active hetero-dimer form.

Authors:  N H Choi-Miura; K Otsuyama; Y Sano; K Saito; K Takahashi; M Tomita
Journal:  Biol Pharm Bull       Date:  2001-08       Impact factor: 2.233

8.  Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.

Authors:  Enders K O Ng; Nancy B Y Tsui; Nicole Y L Lam; Rossa W K Chiu; Simon C H Yu; S C Cesar Wong; Elena S F Lo; Timothy H Rainer; Philip J Johnson; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

9.  The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).

Authors:  J Roemisch; A Feussner; C Nerlich; H-A Stoehr; T Weimer
Journal:  Blood Coagul Fibrinolysis       Date:  2002-07       Impact factor: 1.276

10.  Human endothelial cells selectively express large amounts of pancreatic-type ribonuclease (RNase 1).

Authors:  Julien B P Landré; Peter W Hewett; Jean-Marc Olivot; Peter Friedl; Yon Ko; Agapios Sachinidis; Michel Moenner
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

View more
  32 in total

Review 1.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

2.  Histone H4 promotes prothrombin autoactivation.

Authors:  Sergio Barranco-Medina; Nicola Pozzi; Austin D Vogt; Enrico Di Cera
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

Review 3.  Propagation of thrombosis by neutrophils and extracellular nucleosome networks.

Authors:  Susanne Pfeiler; Konstantin Stark; Steffen Massberg; Bernd Engelmann
Journal:  Haematologica       Date:  2016-12-07       Impact factor: 9.941

4.  DNA and factor VII-activating protease protect against the cytotoxicity of histones.

Authors:  Gerben Marsman; Helen von Richthofen; Ingrid Bulder; Florea Lupu; Jan Hazelzet; Brenda M Luken; Sacha Zeerleder
Journal:  Blood Adv       Date:  2017-11-30

5.  A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding.

Authors:  Boran Altincicek; Aya Shibamiya; Heidi Trusheim; Eleni Tzima; Michael Niepmann; Dietmar Linder; Klaus T Preissner; Sandip M Kanse
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

6.  Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Authors:  Christian Kannemeier; Aya Shibamiya; Fumie Nakazawa; Heidi Trusheim; Clemens Ruppert; Philipp Markart; Yutong Song; Eleni Tzima; Elisabeth Kennerknecht; Michael Niepmann; Marie-Luise von Bruehl; Daniel Sedding; Steffen Massberg; Andreas Günther; Bernd Engelmann; Klaus T Preissner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

Review 7.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

8.  Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS).

Authors:  Malgorzata Wygrecka; Philipp Markart; Ludger Fink; Andreas Guenther; Klaus T Preissner
Journal:  Thorax       Date:  2007-05-04       Impact factor: 9.139

9.  Nucleic acid scavengers inhibit thrombosis without increasing bleeding.

Authors:  Shashank Jain; George A Pitoc; Eda K Holl; Ying Zhang; Luke Borst; Kam W Leong; Jaewoo Lee; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-25       Impact factor: 11.205

10.  Hyaluronic Acid binding protein 2 is a novel regulator of vascular integrity.

Authors:  Nurbek Mambetsariev; Tamara Mirzapoiazova; Bolot Mambetsariev; Saad Sammani; Frances E Lennon; Joe G N Garcia; Patrick A Singleton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-30       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.